If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
498.70    23.40 (4.92%)
Bid:
493.20
Ask:
493.50
Spread: 0.30 (0.061%)
Market Cap: £6.21b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

AGM TRADING UPDATE

29 Apr 2026 07:00

RNS Number : 2917C
Melrose Industries PLC
29 April 2026
 

29 April 2026

 

MELROSE INDUSTRIES PLC - AGM TRADING UPDATE

 

Ahead of its AGM today, Melrose Industries PLC ("Melrose"), a world-leading global aerospace and defence business, announces a trading update for the first quarter ended 31 March 2026 (the "Period"). All growth rates are stated at constant currency.

 

First quarter trading

 

Melrose has made a good start to the year, with a strong financial performance in the first quarter, alongside continued operational and commercial progress. Group revenue grew 11%, reflecting strong progress in Engines, up 20%, and Airframes up 4%. The combination of top line growth and margin progression resulted in adjusted operating profit for the Group and both divisions being well ahead of the same period last year.

 

Engines

 

The performance in Engines was driven by both OE and aftermarket with similar levels of growth in the Period in both segments. Within our RRSP portfolio, OE growth was particularly strong largely driven by deliveries for newer engines. In the aftermarket, all parts of the division delivered good growth with a particularly strong performance in our repairs and military businesses. 

 

Airframes

 

Within Airframes, Defence continues to perform well with double digit growth in the Period driven by our global portfolio. This was partially offset by Civil, where sales were slightly ahead of the comparative period, with good growth across business jets and widebody offset by lower narrowbody volumes, with the latter consistent with the broader market environment. 

 

Group net debt and free cash flow were in line with our expectations.

 

Middle East

The Group has no operating footprint in the Middle East and minimal direct supply chain exposure. While our hedging strategy for utility costs means the Group is well protected in 2026 from increases in energy prices, we are seeing some inflationary pressures in the form of higher freight costs. The potential impact on civil flying hours from reduced jet fuel availability and higher prices is uncertain, and will be dependent on the duration of the conflict.

 

 

Outlook for full year 2026

 

We continue to monitor and manage impacts from the Middle East, working closely with our customers and suppliers. Our guidance for the full year, which assumes no further material impact from the conflict, remains unchanged:

 

· Revenue of £3.75 billion to £3.95 billion

· Adjusted operating profit of £700 million to £750 million, reflecting an adjusted operating margin of c.19% at the mid-point

· Free cash flow generation of £150 million to £200 million (after interest and tax)

· In line with historical and industry seasonality, profit and cash will be second half weighted

· Guidance based on US$ = 1.37 average exchange rate

 

Melrose operates in end markets underpinned by attractive fundamentals, with proprietary technologies and established positions on all the world's leading aircraft. We have seen positive momentum in the first quarter and are well placed to deliver further growth and increased free cash flow in 2026 and the years ahead.

 

Melrose will publish its interim results for the first half ending 30 June 2026 on Friday 31 July 2026.

 

Enquiries:

 

Investor Relations:

Mat Wootton:

+44 (0) 7483 961 233, mat.wootton@melroseplc.net

 

Media:

Simon Sporborg, Tom Pigott / Brunswick:

+44 (0) 207 404 5959, melrose@brunswickgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGZDNRLGVZM
Date   Source Headline
6th Mar 20197:00 amRNSSundry Disposals
19th Dec 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Statement
19th Oct 20183:27 pmRNSAmended Holding(s) in Company
19th Oct 20181:46 pmRNSHolding(s) in Company
17th Oct 20184:47 pmRNSDirector/PDMR Shareholding
8th Oct 201810:30 amRNSAppointment
4th Oct 20184:19 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSAppointment of Director
6th Sep 20187:00 amRNSHalf-year Report
28th Aug 20183:55 pmRNSHolding(s) in Company
28th Aug 20182:22 pmRNSHolding(s) in Company
23rd Aug 20185:07 pmRNSHolding(s) in Company
23rd Aug 20185:06 pmRNSHolding(s) in Company
22nd Aug 20187:00 amRNSNotice of Results
21st Aug 201811:59 amRNSHolding(s) in Company
20th Aug 20186:13 pmRNSHolding(s) in Company
16th Aug 20185:41 pmRNSHolding(s) in Company
10th Aug 20184:09 pmRNSHolding(s) in Company
8th Aug 20184:02 pmRNSVoting Rights and Capital
8th Aug 20181:39 pmRNSHolding(s) in Company
31st Jul 201811:49 amRNSHolding(s) in Company
30th Jul 20189:18 amRNSHolding(s) in Company
5th Jul 20182:25 pmRNSHolding(s) in Company
4th Jul 20184:59 pmRNSHolding(s) in Company
26th Jun 20181:05 pmRNSVoting Rights and Capital
26th Jun 201810:44 amRNSDirector/PDMR Shareholding
25th Jun 20187:00 amRNSCFIUS Clearance
8th Jun 201812:00 pmRNSPDMR Notification
31st May 20182:43 pmRNSVoting Rights and Capital
30th May 20186:04 pmRNSHolding(s) in Company
30th May 201811:36 amRNSHolding(s) in Company
25th May 20184:20 pmRNSDirector/PDMR Shareholding
24th May 20183:08 pmRNSVoting Rights and Capital
22nd May 20184:39 pmRNSHolding(s) in Company
22nd May 20184:34 pmRNSHolding(s) in Company
22nd May 20184:33 pmRNSHolding(s) in Company
22nd May 20184:32 pmRNSHolding(s) in Company
21st May 201810:56 amRNSHolding(s) in Company
21st May 20188:00 amRNSDelisting of GKN & Continuation Of Offer
18th May 20183:54 pmRNSHolding(s) in Company
17th May 20182:59 pmRNSVoting rights and capital
10th May 201812:01 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Trading Update
9th May 20186:14 pmRNSHolding(s) in Company
8th May 20189:18 amRNSHolding(s) in Company
3rd May 20186:11 pmRNSHolding(s) in Company
2nd May 20187:00 amRNSHolding(s) in Company
1st May 20183:47 pmRNSVoting Rights and Capital
1st May 20182:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.